The study on HIV-1 and M-Sec has been published.MORE
We report ACE1 II genotype as a “Factor X”: Why does Asian population have low rates of COVID-19 morbidity and mortality, compared with European population? 2020.7.3
Yamamoto N*, Ariumi Y*(*co-first), Nishida Y, Yamamoto R, Bauer G, Gojobori T, Shimotohno K, Mizokami M. (2020) SARS-CoV-2 infections and COVID-19 mortalities strongly correlate with ACE1 I/D genotype. Gene Jul 3:144944. Online ahead of printMORE
Our center has been posted on an information site of graduate school “Daigakuin ni iko”.MORE
The IKEDA Lab has opened Homepage.HP
Due to concerns over the spread of Coronavirus, we have decided to cancel “Laboratory visit tour”scheduled on April 24, 2020.MORE
Dr. Terumasa Ikeda has joined a member of the Joint Research Center for Human Retrovirus Infection, Kumamoto University as an Associate Professor on January 1st, 2020.
Thank you for your participation in Kickoff Symposium.(2020.1.24) We would like to express our sincere gratitude and appreciation to all of you for the great contribution.PDF
Our lab research proposal on HTLV-1 has been accepted for funding by [AMED] Strategic International Collaborative Research Program. 2019.12.16MORE
Our paper “HTLV-1 contains a high CG dinucleotide content and is susceptible to the host antiviral protein ZAP” is published in Retrovirology. 2019.12.16
Miyazato P, Matsuo M, Tan B, Tokunaga M, Katsuya H, Islam S, Ito J, Murakawa Y, and Satou Y*. HTLV-1 contains high CG dinucleotide content and is susceptible to the host antiviral protein ZAP. Retrovirology, 16, 38, 2019.MORE
Thank you for your participation in the 20th Kumamoto AIDS seminar.
We would like to express our sincere gratitude and appreciation to all of you for the great contribution.